Sunshine Biopharma Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
47
- Stock Symbol
-
SBFM
- Investments
-
2
- Share Price
-
$2.68
- (As of Wednesday Closing)
Sunshine Biopharma General Information
Description
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
Contact Information
Website
www.sunshinebiopharma.comCorporate Office
- 1177 Avenue of the Americas
- 5th Floor
- New York, NY 10036
- United States
Corporate Office
- 1177 Avenue of the Americas
- 5th Floor
- New York, NY 10036
- United States
Sunshine Biopharma Timeline
Sunshine Biopharma Stock Performance
As of 06-Nov-2024, Sunshine Biopharma’s stock price is $2.68. Its current market cap is $5.36M with 2M shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.68 | $2.86 | $2.42 - $637.20 | $5.36M | 2M | 187K | -$127.90 |
Sunshine Biopharma Financials Summary
As of 30-Sep-2024, Sunshine Biopharma has a trailing 12-month revenue of $33M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | (7,024) | (11,200) | (26,101) | 31,361 |
Revenue | 32,959 | 24,093 | 4,346 | 228 |
EBITDA | (4,465) | (4,636) | (26,965) | (12,095) |
Net Income | (4,226) | (4,506) | (26,744) | (12,436) |
Total Assets | 30,057 | 27,347 | 29,244 | 2,203 |
Total Debt | 557 | 658 | 765 | 1,900 |
Sunshine Biopharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Sunshine Biopharma Comparisons
Industry
Financing
Details
Sunshine Biopharma Competitors (9)
One of Sunshine Biopharma’s 9 competitors is Ionis Pharmaceuticals, a Corporate Backed or Acquired company based in Carlsbad, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ionis Pharmaceuticals | Corporate Backed or Acquired | Carlsbad, CA | ||||
Kintara Therapeutics | Corporation | San Diego, CA | ||||
Gilead Sciences | Formerly VC-backed | Foster City, CA | ||||
Amgen | Formerly PE-Backed | Thousand Oaks, CA | ||||
Merck & Co. | Corporation | Rahway, NJ |
Sunshine Biopharma Patents
Sunshine Biopharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230234986-A1 | Inhibitors of coronavirus protease | Pending | 22-May-2020 | ||
US-20150353573-A1 | Gem-difluorinated c-glycoside compounds as anti-cancer agents | Active | 14-Jan-2013 | ||
US-10272065-B2 | Gem-difluorinated c-glycoside compounds as anti-cancer agents | Active | 14-Jan-2013 | ||
EP-3530663-A1 | Process for preparing gem-difluorinated c-glycoside compounds | Active | 14-Jan-2013 | ||
EP-3530663-B1 | Process for preparing gem-difluorinated c-glycoside compounds | Active | 14-Jan-2013 | A61K31/365 |
Sunshine Biopharma Signals
Sunshine Biopharma Acquisitions (2)
Sunshine Biopharma’s most recent deal was a Merger/Acquisition with Nora Pharma for . The deal was made on 20-Oct-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Nora Pharma | 20-Oct-2022 | Merger/Acquisition | Pharmaceuticals | ||
Atlas Pharma | 01-Jan-2018 | Merger/Acquisition | Laboratory Services (Healthcare) |
Sunshine Biopharma Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Nora Pharma | Pharmaceuticals | Varennes, Canada | 2017 |
Atlas Pharma | Laboratory Services (Healthcare) | Montreal, Canada |
Sunshine Biopharma FAQs
-
When was Sunshine Biopharma founded?
Sunshine Biopharma was founded in 2006.
-
Where is Sunshine Biopharma headquartered?
Sunshine Biopharma is headquartered in New York, NY.
-
What is the size of Sunshine Biopharma?
Sunshine Biopharma has 47 total employees.
-
What industry is Sunshine Biopharma in?
Sunshine Biopharma’s primary industry is Drug Discovery.
-
Is Sunshine Biopharma a private or public company?
Sunshine Biopharma is a Public company.
-
What is Sunshine Biopharma’s stock symbol?
The ticker symbol for Sunshine Biopharma is SBFM.
-
What is the current stock price of Sunshine Biopharma?
As of 06-Nov-2024 the stock price of Sunshine Biopharma is $2.68.
-
What is the current market cap of Sunshine Biopharma?
The current market capitalization of Sunshine Biopharma is $5.36M.
-
What is Sunshine Biopharma’s current revenue?
The trailing twelve month revenue for Sunshine Biopharma is $33M.
-
Who are Sunshine Biopharma’s competitors?
Ionis Pharmaceuticals, Kintara Therapeutics, Gilead Sciences, Amgen, and Merck & Co. are some of the 9 competitors of Sunshine Biopharma.
-
What is Sunshine Biopharma’s annual earnings per share (EPS)?
Sunshine Biopharma’s EPS for 12 months was -$127.90.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »